Two studies reveal promising treatments for breast cancer, enhancing options for patients with triple-negative breast cancer ...

Roche shares new data showing its MS drug fenebrutinib maintained low relapse rates and no disability progression in patients ...

Researchers at the Ragon Institute have made a significant discovery about how antibodies can directly enhance the body's ...